ReviewBreast cancer research : BCR2005
Imaging in breast cancer: Single-photon computed tomography and positron-emission tomography.
Review in Breast cancer research : BCR, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
31 citing papers in PubMed.
- Targeting the Oxytocin Receptor for Breast Cancer Management: A Niche for Peptide Tracers.Journal of medicinal chemistry · 2024Review
- Article
- Diabetes, Obesity, and Inflammation: Impact on Clinical and Radiographic Features of Breast Cancer.International journal of molecular sciences · 2021Review
- Review
- Positron Emission Mammography (PEM) in the diagnosis of breast cancer: A systematic review and economic evaluation.Medical journal of the Islamic Republic of Iran · 2020Review
- Imaging Cobalamin Uptake within Malignant Breast Tumors In Vivo.Molecular imaging and biology · 2019Article
- Clinical Potential of Human Epidermal Growth Factor Receptor 2 and Human Epidermal Growth Factor Receptor 3 Imaging in Breast Cancer.PET clinics · 2018Review
- Prorenin receptor acts as a potential molecular target for pancreatic ductal adenocarcinoma diagnosis.Oncotarget · 2016Article
- Ability of contrast-enhanced ultrasonography to determine clinical responses of breast cancer to neoadjuvant chemotherapy.Japanese journal of clinical oncology · 2016Article
- Utilizing the Multiradionuclide Resolving Power of SPECT and Dual Radiolabeled Single Molecules to Assess Treatment Response of Tumors.Molecular imaging and biology · 2015Article
- Development of a Radiolabeled Peptide-Based Probe Targeting MT1-MMP for Breast Cancer Detection.PloS one · 2015Article
- LAT-1 based primary breast cancer detection by [99m]Tc-labeled DTPA-bis-methionine scintimammography: first results using indigenously developed single vial kit preparation.Cancer biotherapy & radiopharmaceuticals · 2014Article
- Molecular photoacoustic tomography of breast cancer using receptor targeted magnetic iron oxide nanoparticles as contrast agents.Journal of biophotonics · 2014Article
- Molecular imaging probes for diagnosis and therapy evaluation of breast cancer.International journal of biomedical imaging · 2013Article
- Advances in molecular imaging for breast cancer detection and characterization.Breast cancer research : BCR · 2012Review
- Synthesis and biological evaluation of water-soluble progesterone-conjugated probes for magnetic resonance imaging of hormone related cancers.Bioconjugate chemistry · 2011Article
- Breast imaging: A survey.World journal of clinical oncology · 2011Article
- Receptor-targeted nanoparticles for in vivo imaging of breast cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2009Article
- Immunoimaging of CXCR4 expression in brain tumor xenografts using SPECT/CT.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2009Article
- Multiparametric monitoring of tumor response to chemotherapy by noninvasive imaging.Cancer research · 2009Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Although mammography remains a key imaging method for the early detection and screening of breast cancer, the overall accuracy of this test remains low. Several radiopharmaceuticals have been proposed as adjunct imaging methods to characterize breast masses by single-photon-emission computed tomography (SPECT) and positron-emission tomography (PET). Useful in characterizing indeterminate palpable masses and in the detection of axillary metastases, these techniques are insufficiently sensitive to detect subcentimetric tumor deposits. Their role in staging nodal involvement of the axillary areas therefore currently remains limited. Several enzymes and receptors have been targeted for imaging breast cancers with PET. [18F]fluorodeoxyglucose is particularly useful in the detection and staging of recurrent breast cancer and in assessing the response to chemotherapy. Several other ligands targeting proliferative activity, protein synthesis, and hormone and cell-membrane receptors may complement this approach by providing unique information about biological characteristics of breast cancer across primary and metastatic tumor sites.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.